Artivion, Inc. (AORT)
23.76
+0.99
(+4.35%)
USD |
NYSE |
May 18, 16:00
23.85
+0.09
(+0.38%)
Pre-Market: 04:40
Artivion Research and Development Expense (Quarterly) : 8.841M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NeuroOne Medical Technologies Corp. | 1.468M |
| Edwards Lifesciences Corp. | 263.30M |
| Zimmer Biomet Holdings, Inc. | 103.40M |
| PetVivo Holdings, Inc. | 0.323M |
| INVO Fertility, Inc. | 0.00 |